The Selective Tyrosine Kinase Inhibitor, STI571, Inhibits Growth of Anaplastic Thyroid Cancer Cells
Alexei Podtcheko(Nagasaki University), Shunichi Yamashita(Fukushima Medical University)
Cited by 82
Related Papers
Dehydroxymethylepoxyquinomicin, a Novel Nuclear Factor-κB Inhibitor, Enhances Antitumor Activity of Taxanes in Anaplastic Thyroid Cancer Cells
|Endocrinology|2008|37
Biological Features Implies Potential Use of Autologous Adipose-Derived Stem/Progenitor Cells in Wound Repair and Regenerations for the Patients with Lipodystrophy
|International Journal of Molecular Sciences|2019|23
Prolonged cetuximab treatment promotes p27Kip1-mediated G1 arrest and autophagy in head and neck squamous cell carcinoma
|Scientific Reports|2021|20
8th International Workshop on Microbeam Probes of Cellular Radiation Response
|Journal of Radiation Research|2009|2